ERBB2 and breast carcinoma: The results showed that this imaging agent was effective in detecting metastases in the lung and other sites in a mouse model, which was not achieved with conventional 18F-FDG-PET imaging, indicating its potential application in the staging and intraoperative resection of HER2-positive breast cancer [66].